Company Valuation: CARE Ratings Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 15,133 19,092 33,416 33,105 43,523 50,873 - -
Change - 26.16% 75.03% -0.93% 31.47% 16.89% - -
Enterprise Value (EV) 15,133 19,092 33,416 33,105 43,523 50,873 50,873 50,873
Change - 26.16% 75.03% -0.93% 31.47% 16.89% 0% 0%
P/E 20.2x 22.8x 33.2x 24.2x 25.5x 25.2x 21.7x 18.9x
PBR 2.34x 2.67x 4.61x 4.07x 4.68x 4.72x 4.12x 3.59x
PEG - 2x 1.7x 0.7x 1x 1.4x 1.4x 1.3x
Capitalization / Revenue 6.11x 6.68x 10.1x 8.23x 9.2x 9.17x 7.98x 6.99x
EV / Revenue 0x 0x 0x 0x 0x 9.17x 7.98x 6.99x
EV / EBITDA 0x 0x 0x 0x 0x 22.1x 18.9x 16.5x
EV / EBIT 0x 0x 0x 0x 0x 23.8x 20.3x 17.7x
EV / FCF 0x 0x 0x 0x 0x 22.7x 19.8x 17.2x
FCF Yield 3.24% 3.71% 2.45% 3.27% 3.2% 4.41% 5.06% 5.8%
Dividend per Share 2 17 17 17 18 14 26.1 28.5 32.5
Rate of return 3.33% 2.64% 1.52% 1.63% 0.97% 1.54% 1.68% 1.92%
EPS 2 25.31 28.17 33.67 45.69 56.83 67.2 77.9 89.5
Distribution rate 67.2% 60.3% 50.5% 39.4% 24.6% 38.8% 36.6% 36.3%
Net sales 1 2,476 2,859 3,317 4,023 4,731 5,545 6,378 7,281
EBITDA 1 798.2 993.4 1,121 1,553 1,974 2,300 2,691 3,092
EBIT 1 721.2 945.2 1,017 1,436 1,830 2,136 2,501 2,869
Net income 1 751.1 835.3 1,005 1,372 1,712 2,021 2,341 2,689
Net Debt - - - - - - - -
Reference price 2 510.45 642.80 1,119.40 1,106.00 1,448.50 1,693.00 1,693.00 1,693.00
Nbr of stocks (in thousands) 29,647 29,701 29,852 29,932 30,047 30,049 - -
Announcement Date 29/5/22 11/5/23 9/5/24 12/5/25 13/5/26 - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
25.66x - - 1.51% 545M
29.22x10.55x19.79x0.88% 82.19B
36.66x - - 1.61% 3.6B
21.2x - - 2.78% 483M
Average 28.18x 10.55x 19.79x 1.7% 21.7B
Weighted average by Cap. 29.46x 10.55x 19.79x 0.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. CARERATING Stock
  4. Valuation CARE Ratings Limited
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!